With this latest win, AJJ Medtech’s total contracted institutional revenue pipeline now exceeds $8 million, which will be recognised over the next three to five years.
AJJ Medtech (SGX:584
) announces that it has won a four-year supply contract valued at approximately $3 million with a network of Singapore healthcare institutions.
The contract, which will commence on June 1, 2026, has a tenure of two years with an option to extend for a further two years, and covers the supply of biodegradable medical consumables.
